These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22186024)

  • 21. ATP13A2/PARK9 regulates secretion of exosomes and α-synuclein.
    Tsunemi T; Hamada K; Krainc D
    J Neurosci; 2014 Nov; 34(46):15281-7. PubMed ID: 25392495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies.
    Murphy KE; Cottle L; Gysbers AM; Cooper AA; Halliday GM
    Acta Neuropathol Commun; 2013 May; 1(1):11. PubMed ID: 24252509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.
    Park JS; Koentjoro B; Veivers D; Mackay-Sim A; Sue CM
    Hum Mol Genet; 2014 Jun; 23(11):2802-15. PubMed ID: 24399444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Lysosomal Exocytosis Induced by Lysosomal Ca
    Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D
    J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H
    Fujii T; Nagamori S; Wiriyasermkul P; Zheng S; Yago A; Shimizu T; Tabuchi Y; Okumura T; Fujii T; Takeshima H; Sakai H
    Nat Commun; 2023 Apr; 14(1):2174. PubMed ID: 37080960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of manganese exposure in Atp13a2-deficient mice.
    Fleming SM; Santiago NA; Mullin EJ; Pamphile S; Karkare S; Lemkuhl A; Ekhator OR; Linn SC; Holden JG; Aga DS; Roth JA; Liou B; Sun Y; Shull GE; Schultheis PJ
    Neurotoxicology; 2018 Jan; 64():256-266. PubMed ID: 28595912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
    Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ
    Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein.
    Dhanushkodi NR; Abul Khair SB; Ardah MT; Haque ME
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity.
    Rinaldi DE; Corradi GR; Cuesta LM; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta; 2015 Aug; 1848(8):1646-55. PubMed ID: 25912790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation.
    Tsunemi T; Ishiguro Y; Yoroisaka A; Valdez C; Miyamoto K; Ishikawa K; Saiki S; Akamatsu W; Hattori N; Krainc D
    J Neurosci; 2020 Nov; 40(45):8618-8628. PubMed ID: 33046546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
    J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.
    Kett LR; Stiller B; Bernath MM; Tasset I; Blesa J; Jackson-Lewis V; Chan RB; Zhou B; Di Paolo G; Przedborski S; Cuervo AM; Dauer WT
    J Neurosci; 2015 Apr; 35(14):5724-42. PubMed ID: 25855184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
    Yang X; Xu Y
    Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.
    Gusdon AM; Zhu J; Van Houten B; Chu CT
    Neurobiol Dis; 2012 Mar; 45(3):962-72. PubMed ID: 22198378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis.
    Rayaprolu S; Seven YB; Howard J; Duffy C; Altshuler M; Moloney C; Giasson BI; Lewis J
    Mol Cell Neurosci; 2018 Oct; 92():17-26. PubMed ID: 29859891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degeneration of dopaminergic neurons and impaired intracellular trafficking in Atp13a2 deficient zebrafish.
    Nyuzuki H; Ito S; Nagasaki K; Nitta Y; Matsui N; Saitoh A; Matsui H
    IBRO Rep; 2020 Dec; 9():1-8. PubMed ID: 32529115
    [No Abstract]   [Full Text] [Related]  

  • 40. Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primates.
    Sikora J; Dovero S; Kinet R; Arotcarena ML; Bohic S; Bezard E; Fernagut PO; Dehay B
    NPJ Parkinsons Dis; 2024 Aug; 10(1):141. PubMed ID: 39090150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.